Surrogate markers in AIDS: where are we? Where are we going? | Ann Intern Med;116(7): 599-601, 1992 Apr 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Surrogate markers in AIDS: where are we? Where are we going?

Lagakos, S W; Hoth, D F.

Ann Intern Med ; 116(7): 599-601, 1992 Apr 01.

Article in En | MEDLINE | ID: mdl-1347443

Subject(s)

Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes/drug effects; Leukocyte Count/drug effects; Acquired Immunodeficiency Syndrome/drug therapy; Biomarkers; Humans; United States; United States Food and Drug Administration

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Acquired Immunodeficiency Syndrome / Leukocyte Count Limits: Humans Country/Region as subject: America do norte Language: En Journal: Ann Intern Med Year: 1992 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Acquired Immunodeficiency Syndrome / Leukocyte Count Limits: Humans Country/Region as subject: America do norte Language: En Journal: Ann Intern Med Year: 1992 Document type: Article Country of publication: United States